TGA Approval

SIMPONI golimumab (rmc) 50 mg/4 mL concentrate for solution for infusion vial (311990)

ARTG ID

311990

ARTG Name

SIMPONI golimumab (rmc) 50 mg/4 mL concentrate for solution for infusion vial

Sponsor

Janssen-Cilag Pty Ltd

ARTG Date

November 20, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

JANSSEN-CILAG PTY LTD

https://medical-cdn.nocode.com/drug_tga/9c345edf04595b0b487c5b9191bdc7fd.pdf

https://medical-cdn.nocode.com/drug_tga/1c19850e951d955961df68370dffc53a.pdf

Ingredient Name

Golimumab

Empowering clinical research with data-driven insights and AI-powered tools.

SIMPONI golimumab (rmc) 50 mg/4 mL concentrate for solution for infusion vial (311990) - TGA 批准文号 | MedPath